ProfileGDS4718 / 203874_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 12% 21% 87% 10% 24% 20% 31% 10% 25% 21% 25% 22% 22% 31% 22% 40% 34% 38% 41% 54% 15% 27% 24% 36% 20% 28% 41% 23% 18% 12% 19% 56% 13% 17% 41% 39% 17% 26% 7% 87% 27% 23% 71% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8762612
GSM549102patient 115, normal, homogenized [OPG study]4.2096621
GSM549104patient 119, normal, homogenized [OPG study]8.7330587
GSM549108patient 138, normal, homogenized [OPG study]3.8174610
GSM549119patient 077, normal, homogenized [OPG study]4.3135924
GSM549133patient 032, cancer, homogenized [OPG study]4.1139820
GSM549139patient 042, cancer, homogenized [OPG study]4.5700831
GSM549099patient 107, normal, homogenized [OPG study]3.7888310
GSM549109patient 139, normal, homogenized [OPG study]4.3731425
GSM549110patient 046, normal, homogenized [OPG study]4.1742521
GSM549114patient 063, normal, homogenized [OPG study]4.2923525
GSM549122patient 082, normal, homogenized [OPG study]4.2288822
GSM549134patient 033, cancer, homogenized [OPG study]4.2024822
GSM549136patient 036, cancer, homogenized [OPG study]4.5397831
GSM549140patient 044, cancer, homogenized [OPG study]4.1758422
GSM549111patient 047, normal, homogenized [OPG study]4.9538940
GSM549113patient 057, normal, homogenized [OPG study]4.6783834
GSM549132patient 031, cancer, homogenized [OPG study]4.9008238
GSM549137patient 038, cancer, homogenized [OPG study]5.0114241
GSM549142patient 047, cancer, homogenized [OPG study]5.8591954
GSM549100patient 110, normal, homogenized [OPG study]3.9763915
GSM549107patient 135, normal, homogenized [OPG study]4.3666827
GSM549115patient 068, normal, homogenized [OPG study]4.248424
GSM549116patient 072, normal, homogenized [OPG study]4.7950136
GSM549120patient 078, normal, homogenized [OPG study]4.1240920
GSM549131patient 030, cancer, homogenized [OPG study]4.4078328
GSM549118patient 074, normal, homogenized [OPG study]5.0361141
GSM549129patient 027, cancer, homogenized [OPG study]4.2548823
GSM549123patient 088, normal, homogenized [OPG study]4.054818
GSM549124patient 006, cancer, homogenized [OPG study]3.8935212
GSM549126patient 015, cancer, homogenized [OPG study]4.0809219
GSM549128patient 025, cancer, homogenized [OPG study]5.894556
GSM549103patient 117, normal, homogenized [OPG study]3.9355913
GSM549117patient 073, normal, homogenized [OPG study]4.0188217
GSM549138patient 041, cancer, homogenized [OPG study]5.0288141
GSM549141patient 045, cancer, homogenized [OPG study]4.880739
GSM549130patient 028, cancer, homogenized [OPG study]4.0482717
GSM549101patient 111, normal, homogenized [OPG study]4.3995626
GSM549105patient 128, normal, homogenized [OPG study]3.688987
GSM549106patient 134, normal, homogenized [OPG study]8.8527787
GSM549112patient 048, normal, homogenized [OPG study]4.3901727
GSM549125patient 011, cancer, homogenized [OPG study]4.2816323
GSM549127patient 024, cancer, homogenized [OPG study]7.0338371
GSM549135patient 035, cancer, homogenized [OPG study]6.8625569